GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Interest Expense

Chi Sheng Pharma & Biotech Co (ROCO:4111) Interest Expense : NT$-2 Mil (TTM As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Chi Sheng Pharma & Biotech Co's interest expense for the three months ended in Dec. 2024 was NT$ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Chi Sheng Pharma & Biotech Co's Operating Income for the three months ended in Dec. 2024 was NT$ 45 Mil. Chi Sheng Pharma & Biotech Co's Interest Expense for the three months ended in Dec. 2024 was NT$ -0 Mil. Chi Sheng Pharma & Biotech Co's Interest Coverage for the quarter that ended in Dec. 2024 was 199.03. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chi Sheng Pharma & Biotech Co Interest Expense Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co Interest Expense Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.16 -1.09 -1.53 -1.46 -1.74

Chi Sheng Pharma & Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.51 -0.50 -0.58 -0.43 -0.23

Chi Sheng Pharma & Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chi Sheng Pharma & Biotech Co  (ROCO:4111) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chi Sheng Pharma & Biotech Co's Interest Expense for the three months ended in Dec. 2024 was NT$-0 Mil. Its Operating Income for the three months ended in Dec. 2024 was NT$45 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was NT$7 Mil.

Chi Sheng Pharma & Biotech Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*45.378/-0.228
=199.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Chi Sheng Pharma & Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Interest Expense
Comparable Companies
ROCO:4116 ROCO:6543 ROCO:6527 ROCO:6730 ROCO:4150 ROCO:7575 ROCO:6518 ROCO:4115 ROCO:6493 TPE:4737 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Website
http://www.cscp.com.tw
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co Headlines

No Headlines